Reviewing Bioqual (OTCMKTS:BIOQ) and Option Care Health (NASDAQ:OPCH)

Option Care Health (NASDAQ:OPCH) and Bioqual (OTCMKTS:BIOQ) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, analyst recommendations and dividends.

Valuation & Earnings

This table compares Option Care Health and Bioqual”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Option Care Health	$5.00 billion	1.08	$211.82 million	$1.26	26.98
Bioqual	$48.87 million	0.69	-$1.05 million	$0.81	46.54

Option Care Health has higher revenue and earnings than Bioqual. Option Care Health is trading at a lower price-to-earnings ratio than Bioqual, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a summary of current recommendations and price targets for Option Care Health and Bioqual, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Option Care Health	0	2	10	1	2.92
Bioqual	0	0	0	0	0.00

Option Care Health currently has a consensus price target of $37.46, suggesting a potential upside of 10.18%. Given Option Care Health’s stronger consensus rating and higher possible upside, equities analysts clearly believe Option Care Health is more favorable than Bioqual.

Volatility and Risk

Option Care Health has a beta of 0.84, suggesting that its stock price is 16% less volatile than the S&P 500. Comparatively, Bioqual has a beta of -0.18, suggesting that its stock price is 118% less volatile than the S&P 500.

Profitability

This table compares Option Care Health and Bioqual’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Option Care Health	3.78%	17.89%	7.20%
Bioqual	1.56%	2.01%	1.30%

Institutional and Insider Ownership

98.1% of Option Care Health shares are owned by institutional investors. 0.6% of Option Care Health shares are owned by insiders. Comparatively, 39.2% of Bioqual shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Option Care Health beats Bioqual on 13 of the 15 factors compared between the two stocks.

About Option Care Health

Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.

About Bioqual

Bioqual, Inc. provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer. Its services also include sample processing, virus stock generation, quantitation of infectious virus, virus neutralization assays, hemagglutination inhibition assay, quantitative PCR, antigen and antibody ELISA detection assays, flow cytometry, lymphocyte proliferation, and other cell-based assays. In addition, the company provides animal research model related services. Bioqual, Inc. was founded in 1981 and is based in Rockville, Maryland.